Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1.

Jiménez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N.

Nat Med. 2000 Jan;6(1):41-8.

PMID:
10613822
2.

c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1.

Jiménez B, Volpert OV, Reiher F, Chang L, Muñoz A, Karin M, Bouck N.

Oncogene. 2001 Jun 7;20(26):3443-8.

3.

Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway.

Nör JE, Mitra RS, Sutorik MM, Mooney DJ, Castle VP, Polverini PJ.

J Vasc Res. 2000 May-Jun;37(3):209-18.

PMID:
10859480
4.

Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).

Kim JS, Chang JH, Yu HK, Ahn JH, Yum JS, Lee SK, Jung KH, Park DH, Yoon Y, Byun SM, Chung SI.

J Biol Chem. 2003 Aug 1;278(31):29000-8.

5.
6.
7.

Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.

Sun J, Blaskovich MA, Jain RK, Delarue F, Paris D, Brem S, Wotoczek-Obadia M, Lin Q, Coppola D, Choi K, Mullan M, Hamilton AD, Sebti SM.

Cancer Res. 2004 May 15;64(10):3586-92.

8.

ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium.

Donnini S, Morbidelli L, Taraboletti G, Ziche M.

Life Sci. 2004 Apr 30;74(24):2975-85.

PMID:
15051421
9.

Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats.

Iruela-Arispe ML, Lombardo M, Krutzsch HC, Lawler J, Roberts DD.

Circulation. 1999 Sep 28;100(13):1423-31.

10.

Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.

Reiher FK, Volpert OV, Jimenez B, Crawford SE, Dinney CP, Henkin J, Haviv F, Bouck NP, Campbell SC.

Int J Cancer. 2002 Apr 10;98(5):682-9.

11.

Alpha4beta1 integrin mediates selective endothelial cell responses to thrombospondins 1 and 2 in vitro and modulates angiogenesis in vivo.

Calzada MJ, Zhou L, Sipes JM, Zhang J, Krutzsch HC, Iruela-Arispe ML, Annis DS, Mosher DF, Roberts DD.

Circ Res. 2004 Mar 5;94(4):462-70.

12.

Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis.

Kanda S, Mochizuki Y, Miyata Y, Kanetake H, Yamamoto N.

J Natl Cancer Inst. 2002 Sep 4;94(17):1311-9.

13.

Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor.

Volpert OV, Zaichuk T, Zhou W, Reiher F, Ferguson TA, Stuart PM, Amin M, Bouck NP.

Nat Med. 2002 Apr;8(4):349-57.

PMID:
11927940
14.

Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.

Jia H, Jezequel S, Löhr M, Shaikh S, Davis D, Soker S, Selwood D, Zachary I.

Biochem Biophys Res Commun. 2001 Apr 27;283(1):164-73.

PMID:
11322784
15.

Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis.

Dixelius J, Larsson H, Sasaki T, Holmqvist K, Lu L, Engström A, Timpl R, Welsh M, Claesson-Welsh L.

Blood. 2000 Jun 1;95(11):3403-11.

16.
18.
19.

Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina.

Sun J, Hopkins BD, Tsujikawa K, Perruzzi C, Adini I, Swerlick R, Bornstein P, Lawler J, Benjamin LE.

Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1344-51. doi: 10.1152/ajpheart.01246.2008.

20.

Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells.

Nakagami H, Morishita R, Yamamoto K, Yoshimura SI, Taniyama Y, Aoki M, Matsubara H, Kim S, Kaneda Y, Ogihara T.

Diabetes. 2001 Jun;50(6):1472-81.

Items per page

Supplemental Content

Support Center